Literature DB >> 15563688

Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2.

Elena Sokolova1, Zoryana Grishina, Frank Bühling, Tobias Welte, Georg Reiser.   

Abstract

Among the four protease-activated receptors (PARs), PAR-1 plays an important role in normal lung functioning and in the development of lung diseases, including fibrosis. We compared the expression and functional activity of PARs in normal and fibrotic human lung fibroblasts. Both normal and fibrotic cells express PAR-1, -2, and -3, with PAR-2 showing the lowest level. There was no significant difference between normal and fibrotic fibroblasts in expression levels of PAR-1 and PAR-3, whereas a fourfold higher expression level of PAR-2 was observed in fibrotic cells compared with normal cells. Ca(2+) imaging studies revealed apparently only PAR-1-induced Ca(2+) signaling in lung fibroblasts. PAR-1 agonists, thrombin and synthetic activating peptide, induced concentration-dependent Ca(2+) mobilization with EC(50) values of 5 nM and 1 microM, respectively. The neutrophil protease cathepsin G produced a transient Ca(2+) response followed by disabling PAR-1, whereas elastase did not affect Ca(2+) level. PAR-1 activation by thrombin or receptor-activating peptide downregulated expression of all three PARs in lung fibroblasts, with maximal effect at 3-6 h, whereas expression returned toward basal level after 24 h. Furthermore, PAR-1 agonists dose dependently increased PGE(2) secretion from lung fibroblasts and induction of cyclooxygenase-2 expression. We then found that PGE(2) downregulated expression of all three PARs. The effect of PGE(2) was continuously growing with time. Furthermore, PGE(2) exerts its effect through the EP2 receptor that was confirmed using the selective EP2 agonist butaprost. This novel autocrine feedback mechanism of PGE(2) in lung fibroblasts seems to be an important regulator in lung physiology and pathology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563688     DOI: 10.1152/ajplung.00343.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  10 in total

1.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Prostaglandin EP1 receptor down-regulates expression of cyclooxygenase-2 by facilitating its proteasomal degradation.

Authors:  Ariz Haddad; Galit Flint-Ashtamker; Waleed Minzel; Rapita Sood; Gilad Rimon; Liza Barki-Harrington
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

3.  Activity of recombinant trypsin isoforms on human proteinase-activated receptors (PAR): mesotrypsin cannot activate epithelial PAR-1, -2, but weakly activates brain PAR-1.

Authors:  Zoryana Grishina; Ewa Ostrowska; Walter Halangk; Miklós Sahin-Tóth; Georg Reiser
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

4.  Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.

Authors:  Olivier Bardou; Awen Menou; Charlène François; Jan Willem Duitman; Jan H von der Thüsen; Raphaël Borie; Katiuchia Uzzun Sales; Kathrin Mutze; Yves Castier; Edouard Sage; Ligong Liu; Thomas H Bugge; David P Fairlie; Mélanie Königshoff; Bruno Crestani; Keren S Borensztajn
Journal:  Am J Respir Crit Care Med       Date:  2016-04-15       Impact factor: 21.405

Review 5.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

6.  Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.

Authors:  William R Coward; Keiria Watts; Carol A Feghali-Bostwick; Alan Knox; Linhua Pang
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

7.  Thrombin-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells.

Authors:  Richard S Sacks; Amy L Firth; Carmelle V Remillard; Negin Agange; Jocelyn Yau; Eun A Ko; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-03       Impact factor: 5.464

8.  Activation of protease-activated receptors (PARs)-1 and -2 promotes alpha-smooth muscle actin expression and release of cytokines from human lung fibroblasts.

Authors:  Nithiananthan Asokananthan; Rommel S Lan; Peter T Graham; Anthony J Bakker; Ana Tokanović; Geoffrey A Stewart
Journal:  Physiol Rep       Date:  2015-02-06

9.  Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.

Authors:  Cong Lin; Jan von der Thüsen; Joost Daalhuisen; Marieke ten Brink; Bruno Crestani; Tom van der Poll; Keren Borensztajn; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2015-02-16       Impact factor: 5.310

Review 10.  Evaluation on potential contributions of protease activated receptors related mediators in allergic inflammation.

Authors:  Huiyun Zhang; Xiaoning Zeng; Shaoheng He
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.